A Phase I, multicenter, study of Th1/Tc1 immunotherapy following autologous Hematopoietic Stem Cell Transplantation in recently diagnosed MM

Sponsor
NIH

Protocol Number
NIH 11-C-0016

To Learn More Call
201-510-0910